Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.7% Jump Turn into More Strength?

Sarepta Therapeutics (SRPT) shares soared 8.7% in the last trading session to close at $79.97. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 30.2% loss over the past four weeks.This rise in share price can be attributed to the recovery in Sarepta’s share price after it tanked earlier this week on reports of a patient’s death following treatment with Elevidys, its one-shot gene therapy for Duchenne muscular dystrophy.This biopha ...